Curepro Parenterals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 13.31 Cr
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -28752.27%
- Ebitda -62.79%
- Net Worth -0.64%
- Total Assets 13.13%
About Curepro Parenterals
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2013PLC087101
- Company No.
087101
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2013
- Date of AGM
24 Aug 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Curepro Parenterals?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivasarao Devathi | CFO | 21-May-2020 | Current |
Venkat Kupireddy | Company Secretary | 10-Jun-2019 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madan Mettu | Director | 21-Aug-2013 | Current |
Sivakumaran Meenakshisunderam | Director | 25-Jun-2015 | Current |
Sarath Penaka | Director | 12-Sep-2013 | Current |
Bhanu Chavali | Whole-Time Director | 27-May-2019 | Current |
Financial Performance of Curepro Parenterals.
Curepro Parenterals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28752.27% decrease in profit. The company's net worth dipped by a decrease of 0.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Curepro Parenterals?
In 2019, Curepro Parenterals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curepro Parenterals?
Unlock and access historical data on people associated with Curepro Parenterals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curepro Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curepro Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.